Piloting Pathways With Lung Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

August 3, 2022

Study Completion Date

August 3, 2022

Conditions
Metastatic Lung Cancer
Interventions
BEHAVIORAL

Pathways

Goal-setting intervention to help patients identify personal values, value-consistent goals, and ways to pursue goals and address goal obstacles. Although potential refinements may occur based on aim 1 (refining procedures and content with 6 patients), Pathways is designed to consist primarily of 2 in-person sessions (\~30-60 minutes) delivered when patients are in clinic for cancer treatment, with supporting phone calls and contact in between sessions.

Trial Locations (1)

40506

University of Kentucky, Lexington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Laurie McLouth

OTHER

NCT04161157 - Piloting Pathways With Lung Cancer Patients | Biotech Hunter | Biotech Hunter